Lv1
20 积分 2026-07-29 加入
Decoding the molecular drivers of TP53‐mutant acute myeloid leukaemia: Clinical implications and prognostic insights
3小时前
已完结
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML
3小时前
已完结
Comparative Safety and Effectiveness of Azacitidine plus Venetoclax versus Intensive Chemotherapy in Acute Myeloid Leukemia: A Propensity Score-Matched Analysis
3小时前
已完结
Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60-75 Years: A Propensity Score–Adjusted Cohort Study
3小时前
已完结
皖公网安备34019202002308
